Recurrent Breast Cancer Terminated Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01009983Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast CancerTreatment